Anna Barkovskaya

Oslo, Norway

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition.

Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition.

Journal: Cell reports
Published: June 17, 2026

Analysis of the current state of frailty indexes and their implementation for aging intervention studies.

Analysis of the current state of frailty indexes and their implementation for aging intervention studies.

Journal: Aging
Published: March 14, 2025

Cell-Surface LAMP1 is a Senescence Marker in Aging and Idiopathic Pulmonary Fibrosis.

Cell-Surface LAMP1 is a Senescence Marker in Aging and Idiopathic Pulmonary Fibrosis.

Journal: Aging cell
Published: March 06, 2025

Mitigating Pro-Inflammatory SASP and DAMP With Urolithin A: A Novel Senomorphic Strategy.

Mitigating Pro-Inflammatory SASP and DAMP With Urolithin A: A Novel Senomorphic Strategy.

Journal: Aging cell
Published: January 29, 2025

Detection of phenotype-specific therapeutic vulnerabilities in breast cells using a CRISPR loss-of-function screen.

Detection of phenotype-specific therapeutic vulnerabilities in breast cells using a CRISPR loss-of-function screen.

Journal: Molecular oncology
Published: August 16, 2020

Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition.

Targeting p130Cas- and microtubule-dependent MYC regulation sensitizes pancreatic cancer to ERK MAPK inhibition.

Journal: Cell reports
Published: July 23, 2020

Proteoglycans as Mediators of Cancer Tissue Mechanics.

Proteoglycans as Mediators of Cancer Tissue Mechanics.

Journal: Frontiers in cell and developmental biology
Published: June 03, 2020

Inhibition of O-GlcNAc transferase activates tumor-suppressor gene expression in tamoxifen-resistant breast cancer cells.

Inhibition of O-GlcNAc transferase activates tumor-suppressor gene expression in tamoxifen-resistant breast cancer cells.

Journal: Scientific reports
Published: April 08, 2020

O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer Subtypes.

O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer Subtypes.

Journal: Scientific reports
Published: December 19, 2018

Metabolic re-wiring of isogenic breast epithelial cell lines following epithelial to mesenchymal transition.

Metabolic re-wiring of isogenic breast epithelial cell lines following epithelial to mesenchymal transition.

Journal: Cancer letters
Published: November 10, 2016

Fibroblast-induced switching to the mesenchymal-like phenotype and PI3K/mTOR signaling protects melanoma cells from BRAF inhibitors.

Fibroblast-induced switching to the mesenchymal-like phenotype and PI3K/mTOR signaling protects melanoma cells from BRAF inhibitors.

Journal: Oncotarget
Published: October 30, 2015

Inhibition of O-GlcNAc transferase activity reprograms prostate cancer cell metabolism.

Inhibition of O-GlcNAc transferase activity reprograms prostate cancer cell metabolism.

Journal: Oncotarget
Published: August 10, 2015
Showing 1-12 of 13

Last Updated: 09/26/2026